Biolife Solutions (BLFS) Stock Price, Quote & News

Company Profile

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induc...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 425 402 1400

Fax: 425 402 1433

Website: www.biolifesolutions.com

Address:

3303 Monte Villa Parkway, Suite 310, Bothell, United States

HyperbolicHodler Aug. 23 at 7:37 AM

$BLFS BioLife Solutions Inc is a biopreservation company facing biotech funding environment challenges

0 · Reply

Rabinovich Aug. 22 at 12:16 AM

$BLFS Right. I think with revenue of $80M per year this should be valued at $2B, in line with SRPT valuation, which has 15x higher revenues and FCF of $800M per year. Why not?

1 · Reply

jpad Aug. 15 at 2:20 AM

$BLFS let’s see what happens tomorrow up or down. Back to 26 then 29

0 · Reply

jpad Aug. 12 at 10:42 PM

$BLFS Zack’s upgraded to strong buy

0 · Reply

Rabinovich Aug. 8 at 4:08 PM

$BLFS 12% up based on nothing. Gotta love this fraud.

0 · Reply

JarvisFlow Aug. 8 at 11:00 AM

HC Wainwright & Co. has updated their rating for BioLife Solutions ( $BLFS ) to Buy with a price target of 32.

0 · Reply

jpad Jul. 23 at 4:42 PM

$BLFS it’s been a while Heading back up again Maybe back to $26

0 · Reply

Rabinovich Jun. 5 at 10:51 AM

$BLFS Fascinating, not a single post in more than 2 weeks. The management enrichment fraud continues in silence. I guess those involved don't mind. The entire cell and gene therapy sector - who theoretically are the customers of this fraud - have been literally obliterated in the last 2 years with several bankruptcies, not profitable companies trading below cash, and profitable businesses trading at 1-2 times current sales. This fraud, however, continues trading at 10-12 times sales with no growth and no profitabilty. Just lol.

1 · Reply

Arcides May. 14 at 10:09 PM

$BLFS expanding down all moving averages on high volume can not be good for longs

0 · Reply

Rabinovich May. 9 at 2:14 PM

$BLFS Lol, this fraud with its miserable quarterly revenues of $25M not even profitable is valued at MC of more than $1B. Management enrichment fraud.

0 · Reply

BioLife Solutions, Inc. (BLFS) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:03 PM EDT - 17 days ago

BioLife Solutions Reports Second Quarter 2025 Financial Results

Jul 28, 2025, 8:05 AM EDT - 27 days ago

BioLife Solutions Makes Strategic Investment in Pluristyx

Jul 24, 2025, 4:05 PM EDT - 4 weeks ago

BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025

May 14, 2025, 8:03 AM EDT - 3 months ago

BioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025

May 8, 2025, 10:59 PM EDT - 3 months ago

BioLife Solutions, Inc. (BLFS) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:32 PM EDT - 3 months ago

BioLife Solutions Updates Earnings Call Information

May 8, 2025, 4:03 PM EDT - 3 months ago

BioLife Solutions Reports First Quarter 2025 Financial Results

May 6, 2025, 8:00 AM EDT - 3 months ago

Stock Picks From Seeking Alpha's April 2025 New Analysts

ACGL ADSK CIG CRWD DPZ EH EL

Apr 30, 2025, 8:03 AM EDT - 4 months ago

BioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025

Apr 7, 2025, 8:03 AM EDT - 4 months ago

BioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables Company

Apr 6, 2025, 4:43 AM EDT - 5 months ago

BioLife Solutions: A Steady Stock Lined Up For Success In A Booming Industry

Mar 18, 2025, 8:30 AM EDT - 5 months ago

BioLife Solutions Appoints Cathy Coste as Director and Audit Committee Chair

Mar 3, 2025, 10:23 AM EST - 6 months ago

BioLife Solutions, Inc. (BLFS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:00 AM EST - 6 months ago

BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 20, 2025, 4:03 PM EST - 6 months ago

BioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025

Jan 13, 2025, 8:30 AM EST - 7 months ago

BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations

Dec 16, 2024, 8:11 AM EST - 8 months ago

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

RGEN

Nov 14, 2024, 4:05 PM EST - 10 months ago

BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary

Nov 12, 2024, 8:41 PM EST - 10 months ago

BioLife Solutions, Inc. (BLFS) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:05 PM EST - 10 months ago

BioLife Solutions Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 8:05 AM EST - 10 months ago

BioLife Solutions Announces $73 Million Sale of its SciSafe Biostorage Subsidiary

Oct 31, 2024, 4:03 PM EDT - 10 months ago

BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024

Aug 20, 2024, 3:51 PM EDT - 1 year ago

BioLife Is Cleaning Ship

Aug 9, 2024, 7:50 PM EDT - 1 year ago

BioLife Solutions, Inc. (BLFS) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:03 PM EDT - 1 year ago

BioLife Solutions Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 4:03 PM EDT - 1 year ago

BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024

May 29, 2024, 8:04 AM EDT - 1 year ago

BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver

May 9, 2024, 8:36 PM EDT - 1 year ago

BioLife Solutions, Inc. (BLFS) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:03 PM EDT - 1 year ago

BioLife Solutions Reports First Quarter 2024 Financial Results

Apr 30, 2024, 4:12 PM EDT - 1 year ago

BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024

Apr 18, 2024, 8:05 AM EDT - 1 year ago

BioLife Solutions Announces the Divestiture of its Stirling Freezer Business

Mar 4, 2024, 8:03 AM EST - 1 year ago

BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences

Feb 29, 2024, 4:03 PM EST - 1 year ago

BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 20, 2024, 8:03 AM EST - 1 year ago

BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024

Jan 8, 2024, 8:15 AM EST - 1 year ago

BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue

Nov 29, 2023, 3:06 PM EST - 1 year ago

BioLife Solutions: A Complicated Tale

Nov 9, 2023, 10:27 PM EST - 1 year ago

BioLife Solutions, Inc. (BLFS) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:04 PM EST - 1 year ago

BioLife Solutions Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 4:03 PM EDT - 1 year ago

BioLife Solutions to Provide Third Quarter 2023 Financial Results and Business Update on November 9, 2023

Oct 19, 2023, 5:04 PM EDT - 2 years ago

BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023

Aug 30, 2023, 8:58 AM EDT - 2 years ago

BioLife Hit By An Inventory Correction

Aug 21, 2023, 7:32 AM EDT - 2 years ago

Top 5 Health Care Stocks That Could Blast Off This Month - Allakos (NASDAQ:ALLK), BioLife Solns (NASDAQ:BLFS)

ALLK KZR TCRT

Aug 8, 2023, 4:03 PM EDT - 2 years ago

BioLife Solutions Reports Second Quarter 2023 Financial Results, Updates Full Year 2023 Guidance and Provides Pro Forma First Half 2023 Financial Profile Excluding Freezer Business

Jul 27, 2023, 4:03 PM EDT - 2 years ago

BioLife Solutions to Provide Second Quarter 2023 Financial Results and Business Update on August 8, 2023

Jun 14, 2023, 8:03 AM EDT - 2 years ago

BioLife Solutions Receives College of American Pathologists CAP-BAP Accreditation for All SciSafe® U.S. Biostorage Facilities

Jun 6, 2023, 8:03 AM EDT - 2 years ago

BioLife Solutions Launches the IntelliRate™ i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer

May 10, 2023, 9:30 PM EDT - 2 years ago

BioLife Solutions, Inc. (BLFS) Q1 2023 Earnings Call Transcript

May 10, 2023, 4:03 PM EDT - 2 years ago

BioLife Solutions Reports First Quarter 2023 Financial Results

May 2, 2023, 4:03 PM EDT - 2 years ago

BioLife Solutions to Provide First Quarter 2023 Financial Results and Business Update on May 10, 2023

HyperbolicHodler Aug. 23 at 7:37 AM

$BLFS BioLife Solutions Inc is a biopreservation company facing biotech funding environment challenges

0 · Reply

Rabinovich Aug. 22 at 12:16 AM

$BLFS Right. I think with revenue of $80M per year this should be valued at $2B, in line with SRPT valuation, which has 15x higher revenues and FCF of $800M per year. Why not?

1 · Reply

jpad Aug. 15 at 2:20 AM

$BLFS let’s see what happens tomorrow up or down. Back to 26 then 29

0 · Reply

jpad Aug. 12 at 10:42 PM

$BLFS Zack’s upgraded to strong buy

0 · Reply

Rabinovich Aug. 8 at 4:08 PM

$BLFS 12% up based on nothing. Gotta love this fraud.

0 · Reply

JarvisFlow Aug. 8 at 11:00 AM

HC Wainwright & Co. has updated their rating for BioLife Solutions ( $BLFS ) to Buy with a price target of 32.

0 · Reply

jpad Jul. 23 at 4:42 PM

$BLFS it’s been a while Heading back up again Maybe back to $26

0 · Reply

Rabinovich Jun. 5 at 10:51 AM

1 · Reply

Arcides May. 14 at 10:09 PM

$BLFS expanding down all moving averages on high volume can not be good for longs

0 · Reply

Rabinovich May. 9 at 2:14 PM

$BLFS Lol, this fraud with its miserable quarterly revenues of $25M not even profitable is valued at MC of more than $1B. Management enrichment fraud.

0 · Reply

lecorb May. 8 at 8:27 PM

$BLFS BioLife Solutions GAAP EPS of -$0.01 beats by $0.04, revenue of $23.9M beats by $1.68M

0 · Reply

PsychedStocks May. 8 at 11:50 AM

$TBRIF $MDXG $EMED $BLFS $MMAT Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin https://www.newsfilecorp.com/release/251233

0 · Reply

Stock__Shark May. 7 at 5:24 PM

$TBRIF $MDXG $EMED $BLFS $MMAT

0 · Reply

PsychedStocks May. 7 at 4:37 PM

$TBRIF Spinning off consumer product portfolio into separate public company by H1 2025 FDA 510K approval for Venowave VW5 unlocks Medicare/Medicaid reimbursement market Revolutionizing vascular health with innovative medical devices and nationwide distribution $MDXG $EMED $BLFS $MMAT

0 · Reply

Rage_Against_The_Machine Apr. 30 at 12:13 PM

$BLFS reports Q1 2025 results May 8th. Investors will watch for signs of revenue stabilization after last year's 43% drop. Improved gross margins (65.3%) and $95M cash cushion could soften the blow if guidance disappoints. High P/S ratio of 14.3 leaves little room for error. https://www.prnewswire.com/news-releases/biolife-solutions-to-report-first-quarter-2025-financial-results-and-business-update-on-may-8-2025-302441713.html

0 · Reply

jpad Apr. 25 at 9:23 AM

$BLFS how high does it go this this time

0 · Reply

jpad Apr. 4 at 5:42 PM

$BLFS buying

0 · Reply

jpad Mar. 31 at 7:22 PM

$BLFS what happened!!

0 · Reply

NVDAMillionaire Mar. 27 at 5:37 PM

$BLFS Digging the cell therapy play. BioLife's strategic pivot looks promising - higher margins, focused biz model. Cell Processing segment showing real strength. Watching for continued growth in CGT market. Might take a small position to play the trend. notable article: https://beyondspx.com/article/biolife-solutions-inc-nasdaq-blfs-a-transformative-shift-toward-enabling-cell-and-gene-therapies

0 · Reply

stockpicker63 Mar. 27 at 5:30 PM

Stocks to watch today! $MUSA, $FRME, $BLFS, $FUL .

1 · Reply

jpad Mar. 26 at 10:12 AM

$BLFS why don’t they people manipulating this stock let it go up to $30

0 · Reply

JarvisFlow Mar. 6 at 11:00 AM

HC Wainwright & Co. has updated their rating for BioLife Solutions ( $BLFS ) to Buy with a price target of 30.

0 · Reply

Market Cap	1.24B
Revenue (ttm)	82.25M
Net Income (ttm)	-20.18M
EPS (ttm)	N/A
PE Ratio	2,508.00
Forward PE	501.60
Profit Margin	-24.54%
Debt to Equity Ratio	0.03

Volume	652,100
Avg Vol	550,462
Day's Range	N/A - N/A
Shares Out	47.91M
Stochastic %K	91%
Beta	1.76
Analysts	Strong Sell
Price Target	$31.30